Geneviève Favre

The sympathomimetic agonist mirabegron did not lower <i>JAK2</i>-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14

Beatrice Drexler, Jakob Passweg, Alexandar Tzankov et al. · Haematologica · 2018 · 35 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +11

Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data

Melanie Premstaller, Melanie Perren, Kuebra Koçack et al. · Journal of clinical lipidology · 2017 · 23 citations

Medicine, Hematology, Pharmacotherapy +16

Repeated peripheral stem cell mobilization in healthy donors: time‐dependent changes in mobilization efficiency

André Tichelli, Jakob Passweg, Till Hoffmann et al. · British Journal of Haematology · 1999 · 21 citations · Full text

Medicine, Cell Biology, Hematology +15

Immunomodulation with romiplostim as a second‐line strategy in primary immune thrombocytopenia: The <scp>iROM</scp> study

Alexandra Schifferli, Axel Rüfer, Alicia Rovó et al. · British Journal of Haematology · 2023 · 11 citations · Full text

Medicine, Hematology, Pharmacotherapy +15